Percutaneous Sclerotherapy for Facial Venous Malformations: Subjective Clinical and Objective MR Imaging Follow-Up Results

References

1. 1.↵
   1. Legiehn GM,
   2. Heran MK

   . Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am 2008;46:545–97

   CrossRefPubMed
2. 2.↵
   1. Rautio R,
   2. Laranne J,
   3. Kahara V,
   4. et al

   . Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck. Acta Radiol 2004;45:738–45

   CrossRefPubMed
3. 3.↵
   1. Goyal M,
   2. Cause PA,
   3. Armstrong D

   . Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 2002;223:639–44

   PubMed
4. 4.↵
   1. Dubois J,
   2. Soulez G,
   3. Oliva VL,
   4. et al

   . Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 2001;21:1519–31

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Hyodoh H,
   2. Hori M,
   3. Akiba H,
   4. et al

   . Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics 2005;25:S159–71

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Konez O,
   2. Burrows PE

   . Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 2002;10:363–88

   CrossRefPubMed
7. 7.↵
   1. Muir T,
   2. Kirsten M,
   3. Fourie P,
   4. et al

   . Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004;19:766–73

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Zhao JH,
   2. Zhang WF,
   3. Zhao YF

   . Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg 2004;33:463–66

   CrossRefPubMed
9. 9.↵
   1. Jin Y,
   2. Lin X,
   3. Li W,
   4. et al

   . Sclerotherapy after embolization of draining vein: a safe treatment for venous malformations. J Vasc Surg 2008;47:1292–99

   CrossRefPubMed
10. 10.↵
    1. Tan KT,
    2. Kirby J,
    3. Rajan D,
    4. et al

    . Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single centre experience. J Vasc Interv Radiol 2007;18:343–51

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Kaban L,
    2. Mulliken JB

    . Vascular anomalies of the maxillofacial region. J Oral Maxillofac Surg 1986;44:203–13

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Agid R,
    2. Burvin R,
    3. Gomori J

    . Sclerotherapy for venous malformations using a “negative subtraction” technique. Neuroradiology 2006;48:127–29

    CrossRefPubMed
13. 13.↵
    1. Ionescu G,
    2. Mabeta P,
    3. Dippenaar N,
    4. et al

    . Bleomycin plasma spill-over levels in paediatric patients undergoing intralesional injection for the treatment of haemangiomas. S Afr Med J 2008;98:539–40

    PubMed
14. 14.↵
    1. Tai KW,
    2. Chang YC,
    3. Chou LS,
    4. et al

    . Cytotoxic effects of pingyangmycin on cultured KB cells. Oral Oncol 1998;34:219–23

    CrossRefPubMed
15. 15.↵
    1. Choi YH,
    2. Han MH,
    3. Kwon OK,
    4. et al

    . Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002;13:475–82

    CrossRefPubMed